id	sid	tid	token	lemma	pos
dpc-1605	1	1	dermatology	dermatology	NOUN
dpc-1605	1	2	:	:	PUNCT
dpc-1605	1	3	practical	practical	ADJ
dpc-1605	1	4	and	and	CCONJ
dpc-1605	1	5	conceptual	conceptual	ADJ
dpc-1605	1	6	dermatology	dermatology	NOUN
dpc-1605	1	7	practical	practical	ADJ
dpc-1605	1	8	&	&	CCONJ
dpc-1605	1	9	conceptual	conceptual	ADJ
dpc-1605	1	10	commentary	commentary	NOUN
dpc-1605	1	11	|	|	ADV
dpc-1605	1	12	dermatol	dermatol	ADJ
dpc-1605	1	13	pract	pract	NOUN
dpc-1605	1	14	concept	concept	NOUN
dpc-1605	1	15	.	.	PUNCT
dpc-1605	2	1	2021	2021	NUM
dpc-1605	2	2	;	;	PUNCT
dpc-1605	2	3	11(4	11(4	NUM
dpc-1605	2	4	):	):	PUNCT
dpc-1605	2	5	e	e	X
dpc-1605	2	6	2021120	2021120	NUM
dpc-1605	2	7	1	1	NUM
dpc-1605	2	8	toxicity	toxicity	NOUN
dpc-1605	2	9	of	of	ADP
dpc-1605	2	10	infiltrative	infiltrative	ADJ
dpc-1605	2	11	lidocaine	lidocaine	NOUN
dpc-1605	2	12	in	in	ADP
dpc-1605	2	13	dermatologic	dermatologic	ADJ
dpc-1605	2	14	surgery	surgery	NOUN
dpc-1605	2	15	:	:	PUNCT
dpc-1605	2	16	are	be	AUX
dpc-1605	2	17	current	current	ADJ
dpc-1605	2	18	limits	limit	NOUN
dpc-1605	2	19	valid	valid	ADJ
dpc-1605	2	20	?	?	PUNCT
dpc-1605	3	1	allison	allison	PROPN
dpc-1605	3	2	wang1	wang1	PROPN
dpc-1605	3	3	,	,	PUNCT
dpc-1605	3	4	solomiya	solomiya	PROPN
dpc-1605	3	5	grushchak1	grushchak1	PROPN
dpc-1605	3	6	,	,	PUNCT
dpc-1605	3	7	subuhi	subuhi	PROPN
dpc-1605	3	8	kaul1	kaul1	PROPN
dpc-1605	3	9	,	,	PUNCT
dpc-1605	3	10	patrick	patrick	PROPN
dpc-1605	3	11	k	k	PROPN
dpc-1605	3	12	lee2	lee2	PROPN
dpc-1605	3	13	,	,	PUNCT
dpc-1605	3	14	jerry	jerry	NOUN
dpc-1605	3	15	feldman1	feldman1	NOUN
dpc-1605	3	16	1	1	NUM
dpc-1605	3	17	division	division	NOUN
dpc-1605	3	18	of	of	ADP
dpc-1605	3	19	dermatology	dermatology	NOUN
dpc-1605	3	20	,	,	PUNCT
dpc-1605	3	21	cook	cook	VERB
dpc-1605	3	22	county	county	NOUN
dpc-1605	3	23	health	health	NOUN
dpc-1605	3	24	,	,	PUNCT
dpc-1605	3	25	chicago	chicago	PROPN
dpc-1605	3	26	,	,	PUNCT
dpc-1605	3	27	il	il	PROPN
dpc-1605	3	28	,	,	PUNCT
dpc-1605	3	29	usa	usa	PROPN
dpc-1605	3	30	2	2	NUM
dpc-1605	3	31	department	department	NOUN
dpc-1605	3	32	of	of	ADP
dpc-1605	3	33	dermatology	dermatology	NOUN
dpc-1605	3	34	,	,	PUNCT
dpc-1605	3	35	university	university	PROPN
dpc-1605	3	36	of	of	ADP
dpc-1605	3	37	california	california	PROPN
dpc-1605	3	38	,	,	PUNCT
dpc-1605	3	39	irvine	irvine	PROPN
dpc-1605	3	40	,	,	PUNCT
dpc-1605	3	41	california	california	PROPN
dpc-1605	3	42	,	,	PUNCT
dpc-1605	3	43	usa	usa	PROPN
dpc-1605	3	44	key	key	NOUN
dpc-1605	3	45	words	word	NOUN
dpc-1605	3	46	:	:	PUNCT
dpc-1605	3	47	lidocaine	lidocaine	NOUN
dpc-1605	3	48	,	,	PUNCT
dpc-1605	3	49	anesthesia	anesthesia	PROPN
dpc-1605	3	50	,	,	PUNCT
dpc-1605	3	51	tumescent	tumescent	NOUN
dpc-1605	3	52	,	,	PUNCT
dpc-1605	3	53	drug	drug	NOUN
dpc-1605	3	54	reaction	reaction	NOUN
dpc-1605	3	55	,	,	PUNCT
dpc-1605	3	56	lidocaine	lidocaine	NOUN
dpc-1605	3	57	-	-	PUNCT
dpc-1605	3	58	associated	associate	VERB
dpc-1605	3	59	systemic	systemic	ADJ
dpc-1605	3	60	toxicity	toxicity	NOUN
dpc-1605	3	61	,	,	PUNCT
dpc-1605	3	62	mohs	mohs	PROPN
dpc-1605	3	63	surgery	surgery	NOUN
dpc-1605	3	64	citation	citation	NOUN
dpc-1605	3	65	:	:	PUNCT
dpc-1605	3	66	wang	wang	PROPN
dpc-1605	3	67	a	a	PROPN
dpc-1605	3	68	,	,	PUNCT
dpc-1605	3	69	grushchak	grushchak	NOUN
dpc-1605	3	70	s	s	PROPN
dpc-1605	3	71	,	,	PUNCT
dpc-1605	3	72	kaul	kaul	PROPN
dpc-1605	3	73	s	s	PROPN
dpc-1605	3	74	,	,	PUNCT
dpc-1605	3	75	lee	lee	PROPN
dpc-1605	3	76	pk	pk	PROPN
dpc-1605	3	77	,	,	PUNCT
dpc-1605	3	78	feldman	feldman	PROPN
dpc-1605	3	79	j.	j.	PROPN
dpc-1605	3	80	toxicity	toxicity	NOUN
dpc-1605	3	81	of	of	ADP
dpc-1605	3	82	infiltrative	infiltrative	ADJ
dpc-1605	3	83	lidocaine	lidocaine	NOUN
dpc-1605	3	84	in	in	ADP
dpc-1605	3	85	dermatologic	dermatologic	ADJ
dpc-1605	3	86	surgery	surgery	NOUN
dpc-1605	3	87	:	:	PUNCT
dpc-1605	3	88	are	be	AUX
dpc-1605	3	89	current	current	ADJ
dpc-1605	3	90	limits	limit	NOUN
dpc-1605	3	91	valid	valid	ADJ
dpc-1605	3	92	?	?	PUNCT
dpc-1605	4	1	dermatol	dermatol	ADJ
dpc-1605	4	2	pract	pract	PROPN
dpc-1605	4	3	concept	concept	NOUN
dpc-1605	4	4	.	.	PUNCT
dpc-1605	5	1	2021	2021	NUM
dpc-1605	5	2	;	;	PUNCT
dpc-1605	5	3	11(4	11(4	NUM
dpc-1605	5	4	):	):	PUNCT
dpc-1605	5	5	e	e	X
dpc-1605	5	6	2021120	2021120	NUM
dpc-1605	5	7	.	.	PUNCT
dpc-1605	6	1	doi	doi	NOUN
dpc-1605	6	2	:	:	PUNCT
dpc-1605	6	3	https://doi.org/10.5826/dpc.1104a120	https://doi.org/10.5826/dpc.1104a120	ADJ
dpc-1605	6	4	accepted	accept	VERB
dpc-1605	6	5	:	:	PUNCT
dpc-1605	6	6	march	march	PROPN
dpc-1605	6	7	23	23	NUM
dpc-1605	6	8	,	,	PUNCT
dpc-1605	6	9	2021	2021	NUM
dpc-1605	6	10	;	;	PUNCT
dpc-1605	6	11	published	publish	VERB
dpc-1605	6	12	:	:	PUNCT
dpc-1605	7	1	september	september	PROPN
dpc-1605	7	2	2021	2021	NUM
dpc-1605	7	3	copyright	copyright	NOUN
dpc-1605	7	4	:	:	PUNCT
dpc-1605	7	5	©	©	PROPN
dpc-1605	7	6	2021	2021	NUM
dpc-1605	7	7	wang	wang	PROPN
dpc-1605	7	8	et	et	PROPN
dpc-1605	7	9	al	al	PROPN
dpc-1605	7	10	.	.	PUNCT
dpc-1605	8	1	this	this	PRON
dpc-1605	8	2	is	be	AUX
dpc-1605	8	3	an	an	DET
dpc-1605	8	4	open	open	ADJ
dpc-1605	8	5	-	-	PUNCT
dpc-1605	8	6	access	access	NOUN
dpc-1605	8	7	article	article	NOUN
dpc-1605	8	8	distributed	distribute	VERB
dpc-1605	8	9	under	under	ADP
dpc-1605	8	10	the	the	DET
dpc-1605	8	11	terms	term	NOUN
dpc-1605	8	12	of	of	ADP
dpc-1605	8	13	the	the	DET
dpc-1605	8	14	creative	creative	ADJ
dpc-1605	8	15	commons	common	NOUN
dpc-1605	8	16	attribution	attribution	NOUN
dpc-1605	8	17	license	license	NOUN
dpc-1605	8	18	by	by	ADP
dpc-1605	8	19	-	-	PUNCT
dpc-1605	8	20	nc-4.0	nc-4.0	NOUN
dpc-1605	8	21	,	,	PUNCT
dpc-1605	8	22	which	which	PRON
dpc-1605	8	23	permits	permit	VERB
dpc-1605	8	24	unrestricted	unrestricted	ADJ
dpc-1605	8	25	noncommercial	noncommercial	ADJ
dpc-1605	8	26	use	use	NOUN
dpc-1605	8	27	,	,	PUNCT
dpc-1605	8	28	distribution	distribution	NOUN
dpc-1605	8	29	,	,	PUNCT
dpc-1605	8	30	and	and	CCONJ
dpc-1605	8	31	reproduction	reproduction	NOUN
dpc-1605	8	32	in	in	ADP
dpc-1605	8	33	any	any	DET
dpc-1605	8	34	medium	medium	NOUN
dpc-1605	8	35	,	,	PUNCT
dpc-1605	8	36	provided	provide	VERB
dpc-1605	8	37	the	the	DET
dpc-1605	8	38	original	original	ADJ
dpc-1605	8	39	authors	author	NOUN
dpc-1605	8	40	and	and	CCONJ
dpc-1605	8	41	source	source	NOUN
dpc-1605	8	42	are	be	AUX
dpc-1605	8	43	credited	credit	VERB
dpc-1605	8	44	.	.	PUNCT
dpc-1605	9	1	funding	funding	NOUN
dpc-1605	9	2	:	:	PUNCT
dpc-1605	9	3	none	none	NOUN
dpc-1605	9	4	.	.	PUNCT
dpc-1605	10	1	competing	compete	VERB
dpc-1605	10	2	interests	interest	NOUN
dpc-1605	10	3	:	:	PUNCT
dpc-1605	10	4	none	none	NOUN
dpc-1605	10	5	.	.	PUNCT
dpc-1605	11	1	authorship	authorship	NOUN
dpc-1605	11	2	:	:	PUNCT
dpc-1605	11	3	all	all	DET
dpc-1605	11	4	authors	author	NOUN
dpc-1605	11	5	have	have	AUX
dpc-1605	11	6	contributed	contribute	VERB
dpc-1605	11	7	significantly	significantly	ADV
dpc-1605	11	8	to	to	ADP
dpc-1605	11	9	this	this	DET
dpc-1605	11	10	publication	publication	NOUN
dpc-1605	11	11	.	.	PUNCT
dpc-1605	12	1	corresponding	correspond	VERB
dpc-1605	12	2	author	author	NOUN
dpc-1605	12	3	:	:	PUNCT
dpc-1605	12	4	subuhi	subuhi	PROPN
dpc-1605	12	5	kaul	kaul	PROPN
dpc-1605	12	6	,	,	PUNCT
dpc-1605	12	7	md	md	PROPN
dpc-1605	12	8	,	,	PUNCT
dpc-1605	12	9	division	division	NOUN
dpc-1605	12	10	of	of	ADP
dpc-1605	12	11	dermatology	dermatology	NOUN
dpc-1605	12	12	,	,	PUNCT
dpc-1605	12	13	cook	cook	VERB
dpc-1605	12	14	county	county	NOUN
dpc-1605	12	15	health	health	NOUN
dpc-1605	12	16	,	,	PUNCT
dpc-1605	12	17	professional	professional	ADJ
dpc-1605	12	18	building	building	NOUN
dpc-1605	12	19	,	,	PUNCT
dpc-1605	12	20	6th	6th	ADJ
dpc-1605	12	21	floor	floor	NOUN
dpc-1605	12	22	,	,	PUNCT
dpc-1605	12	23	1950	1950	NUM
dpc-1605	12	24	w.	w.	PROPN
dpc-1605	12	25	polk	polk	PROPN
dpc-1605	12	26	st	st	PROPN
dpc-1605	12	27	,	,	PUNCT
dpc-1605	12	28	chicago	chicago	PROPN
dpc-1605	12	29	,	,	PUNCT
dpc-1605	12	30	il	il	PROPN
dpc-1605	12	31	,	,	PUNCT
dpc-1605	12	32	usa	usa	PROPN
dpc-1605	12	33	.	.	PROPN
dpc-1605	12	34	email	email	NOUN
dpc-1605	12	35	:	:	PUNCT
dpc-1605	12	36	subuhi.kaul@cookcountyhhs.org	subuhi.kaul@cookcountyhhs.org	PROPN
dpc-1605	12	37	local	local	ADJ
dpc-1605	12	38	infiltrative	infiltrative	ADJ
dpc-1605	12	39	lidocaine	lidocaine	NOUN
dpc-1605	12	40	is	be	AUX
dpc-1605	12	41	the	the	DET
dpc-1605	12	42	most	most	ADV
dpc-1605	12	43	common	common	ADJ
dpc-1605	12	44	anesthetic	anesthetic	NOUN
dpc-1605	12	45	method	method	NOUN
dpc-1605	12	46	used	use	VERB
dpc-1605	12	47	in	in	ADP
dpc-1605	12	48	dermatologic	dermatologic	ADJ
dpc-1605	12	49	surgery	surgery	NOUN
dpc-1605	12	50	.	.	PUNCT
dpc-1605	13	1	according	accord	VERB
dpc-1605	13	2	to	to	ADP
dpc-1605	13	3	the	the	DET
dpc-1605	13	4	food	food	NOUN
dpc-1605	13	5	and	and	CCONJ
dpc-1605	13	6	drug	drug	NOUN
dpc-1605	13	7	administration	administration	NOUN
dpc-1605	13	8	,	,	PUNCT
dpc-1605	13	9	the	the	DET
dpc-1605	13	10	maximum	maximum	PROPN
dpc-1605	13	11	dose	dose	NOUN
dpc-1605	13	12	of	of	ADP
dpc-1605	13	13	infiltrative	infiltrative	ADJ
dpc-1605	13	14	lidocaine	lidocaine	NOUN
dpc-1605	13	15	with	with	ADP
dpc-1605	13	16	and	and	CCONJ
dpc-1605	13	17	without	without	ADP
dpc-1605	13	18	epinephrine	epinephrine	NOUN
dpc-1605	13	19	is	be	AUX
dpc-1605	13	20	7mg	7mg	ADJ
dpc-1605	13	21	/	/	SYM
dpc-1605	13	22	kg	kg	PROPN
dpc-1605	13	23	and	and	CCONJ
dpc-1605	13	24	4.5mg/	4.5mg/	NUM
dpc-1605	13	25	kg	kg	NOUN
dpc-1605	13	26	in	in	ADP
dpc-1605	13	27	adults	adult	NOUN
dpc-1605	13	28	,	,	PUNCT
dpc-1605	13	29	respectively	respectively	ADV
dpc-1605	13	30	[	[	X
dpc-1605	13	31	1	1	NUM
dpc-1605	13	32	]	]	PUNCT
dpc-1605	13	33	.	.	PUNCT
dpc-1605	14	1	data	datum	NOUN
dpc-1605	14	2	analyzing	analyze	VERB
dpc-1605	14	3	the	the	DET
dpc-1605	14	4	validity	validity	NOUN
dpc-1605	14	5	of	of	ADP
dpc-1605	14	6	the	the	DET
dpc-1605	14	7	proposed	propose	VERB
dpc-1605	14	8	dosages	dosage	NOUN
dpc-1605	14	9	is	be	AUX
dpc-1605	14	10	lacking	lack	VERB
dpc-1605	14	11	,	,	PUNCT
dpc-1605	14	12	yet	yet	CCONJ
dpc-1605	14	13	these	these	DET
dpc-1605	14	14	recommendations	recommendation	NOUN
dpc-1605	14	15	are	be	AUX
dpc-1605	14	16	widely	widely	ADV
dpc-1605	14	17	accepted	accept	VERB
dpc-1605	14	18	.	.	PUNCT
dpc-1605	15	1	we	we	PRON
dpc-1605	15	2	aim	aim	VERB
dpc-1605	15	3	to	to	PART
dpc-1605	15	4	review	review	VERB
dpc-1605	15	5	the	the	DET
dpc-1605	15	6	origin	origin	NOUN
dpc-1605	15	7	and	and	CCONJ
dpc-1605	15	8	steadfastness	steadfastness	NOUN
dpc-1605	15	9	of	of	ADP
dpc-1605	15	10	the	the	DET
dpc-1605	15	11	maximum	maximum	ADJ
dpc-1605	15	12	doses	dose	NOUN
dpc-1605	15	13	of	of	ADP
dpc-1605	15	14	lidocaine	lidocaine	NOUN
dpc-1605	15	15	for	for	ADP
dpc-1605	15	16	infiltrative	infiltrative	ADJ
dpc-1605	15	17	anesthesia	anesthesia	NOUN
dpc-1605	15	18	in	in	ADP
dpc-1605	15	19	cutaneous	cutaneous	ADJ
dpc-1605	15	20	surgery	surgery	NOUN
dpc-1605	15	21	.	.	PUNCT
dpc-1605	16	1	the	the	DET
dpc-1605	16	2	maximum	maximum	PROPN
dpc-1605	16	3	lidocaine	lidocaine	NOUN
dpc-1605	16	4	doses	dose	NOUN
dpc-1605	16	5	are	be	AUX
dpc-1605	16	6	manufacturer	manufacturer	NOUN
dpc-1605	16	7	recommendations	recommendation	NOUN
dpc-1605	16	8	based	base	VERB
dpc-1605	16	9	on	on	ADP
dpc-1605	16	10	early	early	ADJ
dpc-1605	16	11	studies	study	NOUN
dpc-1605	16	12	and	and	CCONJ
dpc-1605	16	13	there	there	PRON
dpc-1605	16	14	are	be	VERB
dpc-1605	16	15	no	no	DET
dpc-1605	16	16	randomized	randomized	ADJ
dpc-1605	16	17	trials	trial	NOUN
dpc-1605	16	18	available	available	ADJ
dpc-1605	16	19	to	to	PART
dpc-1605	16	20	validate	validate	VERB
dpc-1605	16	21	this	this	DET
dpc-1605	16	22	regulation	regulation	NOUN
dpc-1605	16	23	[	[	X
dpc-1605	16	24	1	1	NUM
dpc-1605	16	25	]	]	PUNCT
dpc-1605	16	26	.	.	PUNCT
dpc-1605	17	1	moreover	moreover	ADV
dpc-1605	17	2	,	,	PUNCT
dpc-1605	17	3	these	these	DET
dpc-1605	17	4	recommendations	recommendation	NOUN
dpc-1605	17	5	do	do	AUX
dpc-1605	17	6	not	not	PART
dpc-1605	17	7	consider	consider	VERB
dpc-1605	17	8	the	the	DET
dpc-1605	17	9	route	route	NOUN
dpc-1605	17	10	of	of	ADP
dpc-1605	17	11	administration	administration	NOUN
dpc-1605	17	12	.	.	PUNCT
dpc-1605	18	1	lidocaine	lidocaine	PROPN
dpc-1605	18	2	was	be	AUX
dpc-1605	18	3	synthesized	synthesize	VERB
dpc-1605	18	4	in	in	ADP
dpc-1605	18	5	1943	1943	NUM
dpc-1605	18	6	,	,	PUNCT
dpc-1605	18	7	it	it	PRON
dpc-1605	18	8	demonstrated	demonstrate	VERB
dpc-1605	18	9	a	a	DET
dpc-1605	18	10	lethal	lethal	ADJ
dpc-1605	18	11	dose	dose	NOUN
dpc-1605	18	12	of	of	ADP
dpc-1605	18	13	1g	1g	NUM
dpc-1605	18	14	/	/	SYM
dpc-1605	18	15	kg	kg	NOUN
dpc-1605	18	16	with	with	ADP
dpc-1605	18	17	subcutaneous	subcutaneous	ADJ
dpc-1605	18	18	infiltration	infiltration	NOUN
dpc-1605	18	19	of	of	ADP
dpc-1605	18	20	0.5	0.5	NUM
dpc-1605	18	21	%	%	NOUN
dpc-1605	18	22	in	in	ADP
dpc-1605	18	23	rodents	rodent	NOUN
dpc-1605	18	24	[	[	X
dpc-1605	18	25	2	2	NUM
dpc-1605	18	26	]	]	PUNCT
dpc-1605	18	27	.	.	PUNCT
dpc-1605	19	1	in	in	ADP
dpc-1605	19	2	1949	1949	NUM
dpc-1605	19	3	,	,	PUNCT
dpc-1605	19	4	a	a	DET
dpc-1605	19	5	human	human	ADJ
dpc-1605	19	6	trial	trial	NOUN
dpc-1605	19	7	performed	perform	VERB
dpc-1605	19	8	on	on	ADP
dpc-1605	19	9	over	over	ADP
dpc-1605	19	10	800	800	NUM
dpc-1605	19	11	patients	patient	NOUN
dpc-1605	19	12	showed	show	VERB
dpc-1605	19	13	500	500	NUM
dpc-1605	19	14	mg	mg	NOUN
dpc-1605	19	15	and	and	CCONJ
dpc-1605	19	16	1000	1000	NUM
dpc-1605	19	17	mg	mg	NOUN
dpc-1605	19	18	of	of	ADP
dpc-1605	19	19	lidocaine	lidocaine	NOUN
dpc-1605	19	20	(	(	PUNCT
dpc-1605	19	21	with	with	ADP
dpc-1605	19	22	and	and	CCONJ
dpc-1605	19	23	without	without	ADP
dpc-1605	19	24	epinephrine	epinephrine	NOUN
dpc-1605	19	25	,	,	PUNCT
dpc-1605	19	26	respectively	respectively	ADV
dpc-1605	19	27	)	)	PUNCT
dpc-1605	19	28	to	to	PART
dpc-1605	19	29	be	be	AUX
dpc-1605	19	30	safe	safe	ADJ
dpc-1605	19	31	.	.	PUNCT
dpc-1605	20	1	2	2	NUM
dpc-1605	20	2	cases	case	NOUN
dpc-1605	20	3	of	of	ADP
dpc-1605	20	4	systemic	systemic	ADJ
dpc-1605	20	5	toxicity	toxicity	NOUN
dpc-1605	20	6	occurred	occur	VERB
dpc-1605	20	7	after	after	ADP
dpc-1605	20	8	deliberate	deliberate	ADJ
dpc-1605	20	9	overdose	overdose	NOUN
dpc-1605	20	10	with	with	ADP
dpc-1605	20	11	1.35	1.35	NUM
dpc-1605	20	12	g	g	NOUN
dpc-1605	20	13	and	and	CCONJ
dpc-1605	20	14	3	3	NUM
dpc-1605	20	15	g	g	NOUN
dpc-1605	20	16	of	of	ADP
dpc-1605	20	17	lidocaine	lidocaine	NOUN
dpc-1605	20	18	in	in	ADP
dpc-1605	20	19	thoracic	thoracic	NOUN
dpc-1605	20	20	surgeries	surgery	NOUN
dpc-1605	20	21	.	.	PUNCT
dpc-1605	21	1	both	both	DET
dpc-1605	21	2	patients	patient	NOUN
dpc-1605	21	3	experienced	experience	VERB
dpc-1605	21	4	stupor	stupor	NOUN
dpc-1605	21	5	and	and	CCONJ
dpc-1605	21	6	convulsions	convulsion	NOUN
dpc-1605	21	7	,	,	PUNCT
dpc-1605	21	8	which	which	PRON
dpc-1605	21	9	improved	improve	VERB
dpc-1605	21	10	with	with	ADP
dpc-1605	21	11	intravenous	intravenous	ADJ
dpc-1605	21	12	barbiturate	barbiturate	NOUN
dpc-1605	21	13	[	[	X
dpc-1605	21	14	2	2	NUM
dpc-1605	21	15	]	]	PUNCT
dpc-1605	21	16	.	.	PUNCT
dpc-1605	22	1	comparable	comparable	ADJ
dpc-1605	22	2	serum	serum	PROPN
dpc-1605	22	3	lidocaine	lidocaine	NOUN
dpc-1605	22	4	levels	level	NOUN
dpc-1605	22	5	were	be	AUX
dpc-1605	22	6	confirmed	confirm	VERB
dpc-1605	22	7	via	via	ADP
dpc-1605	22	8	different	different	ADJ
dpc-1605	22	9	routes	route	NOUN
dpc-1605	22	10	and	and	CCONJ
dpc-1605	22	11	doses	dose	NOUN
dpc-1605	22	12	:	:	PUNCT
dpc-1605	22	13	500	500	NUM
dpc-1605	22	14	mg	mg	NOUN
dpc-1605	22	15	by	by	ADP
dpc-1605	22	16	epidural	epidural	ADJ
dpc-1605	22	17	administration	administration	NOUN
dpc-1605	22	18	,	,	PUNCT
dpc-1605	22	19	600	600	NUM
dpc-1605	22	20	mg	mg	NOUN
dpc-1605	22	21	in	in	ADP
dpc-1605	22	22	brachial	brachial	ADJ
dpc-1605	22	23	plexus	plexus	NOUN
dpc-1605	22	24	blocks	block	NOUN
dpc-1605	22	25	,	,	PUNCT
dpc-1605	22	26	and	and	CCONJ
dpc-1605	22	27	1,000	1,000	NUM
dpc-1605	22	28	mg	mg	NOUN
dpc-1605	22	29	in	in	ADP
dpc-1605	22	30	subcutaneous	subcutaneous	ADJ
dpc-1605	22	31	infiltration	infiltration	NOUN
dpc-1605	22	32	in	in	ADP
dpc-1605	22	33	legs	leg	NOUN
dpc-1605	22	34	[	[	X
dpc-1605	22	35	1	1	NUM
dpc-1605	22	36	]	]	PUNCT
dpc-1605	22	37	.	.	PUNCT
dpc-1605	23	1	the	the	DET
dpc-1605	23	2	maximum	maximum	PROPN
dpc-1605	23	3	dose	dose	NOUN
dpc-1605	23	4	limits	limit	NOUN
dpc-1605	23	5	tend	tend	VERB
dpc-1605	23	6	to	to	PART
dpc-1605	23	7	err	err	VERB
dpc-1605	23	8	on	on	ADP
dpc-1605	23	9	the	the	DET
dpc-1605	23	10	side	side	NOUN
dpc-1605	23	11	of	of	ADP
dpc-1605	23	12	caution	caution	NOUN
dpc-1605	23	13	and	and	CCONJ
dpc-1605	23	14	are	be	AUX
dpc-1605	23	15	often	often	ADV
dpc-1605	23	16	inadequate	inadequate	ADJ
dpc-1605	23	17	for	for	ADP
dpc-1605	23	18	brachial	brachial	ADJ
dpc-1605	23	19	plexus	plexus	NOUN
dpc-1605	23	20	or	or	CCONJ
dpc-1605	23	21	epidural	epidural	ADJ
dpc-1605	23	22	blocks	block	NOUN
dpc-1605	23	23	and	and	CCONJ
dpc-1605	23	24	are	be	AUX
dpc-1605	23	25	discussed	discuss	VERB
dpc-1605	23	26	in	in	ADP
dpc-1605	23	27	anesthesia	anesthesia	PROPN
dpc-1605	23	28	literature	literature	NOUN
dpc-1605	24	1	[	[	X
dpc-1605	24	2	1,3	1,3	NUM
dpc-1605	24	3	]	]	PUNCT
dpc-1605	24	4	.	.	PUNCT
dpc-1605	25	1	lidocaine	lidocaine	PROPN
dpc-1605	25	2	is	be	AUX
dpc-1605	25	3	eliminated	eliminate	VERB
dpc-1605	25	4	via	via	ADP
dpc-1605	25	5	the	the	DET
dpc-1605	25	6	hepatic	hepatic	ADJ
dpc-1605	25	7	cytochrome	cytochrome	NOUN
dpc-1605	25	8	p450	p450	NUM
dpc-1605	25	9	3a4	3a4	NUM
dpc-1605	25	10	pathway	pathway	NOUN
dpc-1605	26	1	[	[	X
dpc-1605	26	2	1	1	NUM
dpc-1605	26	3	]	]	PUNCT
dpc-1605	26	4	.	.	PUNCT
dpc-1605	27	1	serum	serum	PROPN
dpc-1605	27	2	lidocaine	lidocaine	PROPN
dpc-1605	27	3	concentration	concentration	NOUN
dpc-1605	27	4	depends	depend	VERB
dpc-1605	27	5	on	on	ADP
dpc-1605	27	6	several	several	ADJ
dpc-1605	27	7	factors	factor	NOUN
dpc-1605	27	8	including	include	VERB
dpc-1605	27	9	patient	patient	ADJ
dpc-1605	27	10	and	and	CCONJ
dpc-1605	27	11	injection	injection	NOUN
dpc-1605	27	12	method	method	NOUN
dpc-1605	27	13	.	.	PUNCT
dpc-1605	28	1	severe	severe	ADJ
dpc-1605	28	2	liver	liver	NOUN
dpc-1605	28	3	dysfunction	dysfunction	NOUN
dpc-1605	28	4	or	or	CCONJ
dpc-1605	28	5	medications	medication	NOUN
dpc-1605	28	6	that	that	PRON
dpc-1605	28	7	inhibit	inhibit	VERB
dpc-1605	28	8	cytochrome	cytochrome	NOUN
dpc-1605	28	9	p450	p450	NUM
dpc-1605	28	10	3a4	3a4	NUM
dpc-1605	28	11	,	,	PUNCT
dpc-1605	28	12	such	such	ADJ
dpc-1605	28	13	as	as	ADP
dpc-1605	28	14	,	,	PUNCT
dpc-1605	28	15	itraconazole	itraconazole	NOUN
dpc-1605	28	16	,	,	PUNCT
dpc-1605	28	17	erythromycin	erythromycin	NOUN
dpc-1605	28	18	,	,	PUNCT
dpc-1605	28	19	amiodarone	amiodarone	NOUN
dpc-1605	28	20	,	,	PUNCT
dpc-1605	28	21	cimetidine	cimetidine	NOUN
dpc-1605	28	22	,	,	PUNCT
dpc-1605	28	23	valproate	valproate	NOUN
dpc-1605	28	24	,	,	PUNCT
dpc-1605	28	25	may	may	AUX
dpc-1605	28	26	theoretically	theoretically	ADV
dpc-1605	28	27	result	result	VERB
dpc-1605	28	28	in	in	ADP
dpc-1605	28	29	toxicity	toxicity	NOUN
dpc-1605	28	30	at	at	ADP
dpc-1605	28	31	lower	low	ADJ
dpc-1605	28	32	doses	dose	NOUN
dpc-1605	28	33	[	[	X
dpc-1605	28	34	1	1	NUM
dpc-1605	28	35	,	,	PUNCT
dpc-1605	28	36	4	4	NUM
dpc-1605	28	37	]	]	PUNCT
dpc-1605	28	38	.	.	PUNCT
dpc-1605	29	1	a	a	DET
dpc-1605	29	2	study	study	NOUN
dpc-1605	29	3	on	on	ADP
dpc-1605	29	4	intravenous	intravenous	ADJ
dpc-1605	29	5	administration	administration	NOUN
dpc-1605	29	6	of	of	ADP
dpc-1605	29	7	lidocaine	lidocaine	NOUN
dpc-1605	29	8	showed	show	VERB
dpc-1605	29	9	a	a	DET
dpc-1605	29	10	lower	low	ADJ
dpc-1605	29	11	clearance	clearance	NOUN
dpc-1605	29	12	in	in	ADP
dpc-1605	29	13	patients	patient	NOUN
dpc-1605	29	14	with	with	ADP
dpc-1605	29	15	child	child	NOUN
dpc-1605	29	16	c	c	NOUN
dpc-1605	29	17	cirrhosis	cirrhosis	NOUN
dpc-1605	29	18	and	and	CCONJ
dpc-1605	29	19	concluded	conclude	VERB
dpc-1605	29	20	that	that	SCONJ
dpc-1605	29	21	a	a	DET
dpc-1605	29	22	50	50	NUM
dpc-1605	29	23	%	%	NOUN
dpc-1605	29	24	reduction	reduction	NOUN
dpc-1605	29	25	in	in	ADP
dpc-1605	29	26	dosage	dosage	NOUN
dpc-1605	29	27	was	be	AUX
dpc-1605	29	28	necessary	necessary	ADJ
dpc-1605	29	29	in	in	ADP
dpc-1605	29	30	these	these	DET
dpc-1605	29	31	patients	patient	NOUN
dpc-1605	29	32	[	[	X
dpc-1605	29	33	5	5	NUM
dpc-1605	29	34	]	]	PUNCT
dpc-1605	29	35	.	.	PUNCT
dpc-1605	30	1	further	further	ADJ
dpc-1605	30	2	studies	study	NOUN
dpc-1605	30	3	showed	show	VERB
dpc-1605	30	4	that	that	SCONJ
dpc-1605	30	5	dose	dose	NOUN
dpc-1605	30	6	reduction	reduction	NOUN
dpc-1605	30	7	is	be	AUX
dpc-1605	30	8	only	only	ADV
dpc-1605	30	9	indicated	indicate	VERB
dpc-1605	30	10	with	with	ADP
dpc-1605	30	11	repeated	repeat	VERB
dpc-1605	30	12	blocks	block	NOUN
dpc-1605	30	13	administered	administer	VERB
dpc-1605	30	14	less	less	ADJ
dpc-1605	30	15	than	than	ADP
dpc-1605	30	16	5	5	NUM
dpc-1605	30	17	half	half	ADJ
dpc-1605	30	18	-	-	PUNCT
dpc-1605	30	19	lives	life	NOUN
dpc-1605	30	20	apart	apart	ADV
dpc-1605	30	21	or	or	CCONJ
dpc-1605	30	22	with	with	ADP
dpc-1605	30	23	continuous	continuous	ADJ
dpc-1605	30	24	infusion	infusion	NOUN
dpc-1605	30	25	,	,	PUNCT
dpc-1605	30	26	2	2	NUM
dpc-1605	30	27	commentary	commentary	NOUN
dpc-1605	30	28	|	|	ADV
dpc-1605	30	29	dermatol	dermatol	ADJ
dpc-1605	30	30	pract	pract	NOUN
dpc-1605	30	31	concept	concept	NOUN
dpc-1605	30	32	.	.	PUNCT
dpc-1605	31	1	2021	2021	NUM
dpc-1605	31	2	;	;	PUNCT
dpc-1605	31	3	11(4	11(4	NUM
dpc-1605	31	4	):	):	PUNCT
dpc-1605	31	5	e	e	NOUN
dpc-1605	31	6	2021120	2021120	NUM
dpc-1605	31	7	as	as	SCONJ
dpc-1605	31	8	lidocaine	lidocaine	NOUN
dpc-1605	31	9	accumulates	accumulate	VERB
dpc-1605	31	10	in	in	ADP
dpc-1605	31	11	cirrhotic	cirrhotic	ADJ
dpc-1605	31	12	patients	patient	NOUN
dpc-1605	32	1	[	[	X
dpc-1605	32	2	1	1	NUM
dpc-1605	32	3	]	]	PUNCT
dpc-1605	32	4	.	.	PUNCT
dpc-1605	33	1	notably	notably	ADV
dpc-1605	33	2	,	,	PUNCT
dpc-1605	33	3	plasma	plasma	NOUN
dpc-1605	33	4	levels	level	NOUN
dpc-1605	33	5	attained	attain	VERB
dpc-1605	33	6	after	after	SCONJ
dpc-1605	33	7	subcutaneous	subcutaneous	ADJ
dpc-1605	33	8	injection	injection	NOUN
dpc-1605	33	9	are	be	AUX
dpc-1605	33	10	lower	low	ADJ
dpc-1605	33	11	than	than	ADP
dpc-1605	33	12	that	that	PRON
dpc-1605	33	13	by	by	ADP
dpc-1605	33	14	intravenous	intravenous	ADJ
dpc-1605	33	15	injection	injection	NOUN
dpc-1605	33	16	,	,	PUNCT
dpc-1605	33	17	thus	thus	ADV
dpc-1605	33	18	adjustment	adjustment	NOUN
dpc-1605	33	19	of	of	ADP
dpc-1605	33	20	dose	dose	NOUN
dpc-1605	33	21	may	may	AUX
dpc-1605	33	22	not	not	PART
dpc-1605	33	23	be	be	AUX
dpc-1605	33	24	necessary	necessary	ADJ
dpc-1605	33	25	after	after	ADP
dpc-1605	33	26	subcutaneous	subcutaneous	ADJ
dpc-1605	33	27	injection	injection	NOUN
dpc-1605	33	28	,	,	PUNCT
dpc-1605	33	29	especially	especially	ADV
dpc-1605	33	30	if	if	SCONJ
dpc-1605	33	31	only	only	ADV
dpc-1605	33	32	a	a	DET
dpc-1605	33	33	single	single	ADJ
dpc-1605	33	34	dose	dose	NOUN
dpc-1605	33	35	is	be	AUX
dpc-1605	33	36	required	require	VERB
dpc-1605	33	37	[	[	X
dpc-1605	33	38	1	1	NUM
dpc-1605	33	39	]	]	PUNCT
dpc-1605	33	40	.	.	PUNCT
dpc-1605	34	1	infiltration	infiltration	NOUN
dpc-1605	34	2	with	with	ADP
dpc-1605	34	3	epinephrine	epinephrine	NOUN
dpc-1605	34	4	(	(	PUNCT
dpc-1605	34	5	potent	potent	ADJ
dpc-1605	34	6	vasoconstrictor	vasoconstrictor	NOUN
dpc-1605	34	7	)	)	PUNCT
dpc-1605	34	8	or	or	CCONJ
dpc-1605	34	9	as	as	ADP
dpc-1605	34	10	a	a	DET
dpc-1605	34	11	diluted	diluted	ADJ
dpc-1605	34	12	solution	solution	NOUN
dpc-1605	34	13	,	,	PUNCT
dpc-1605	34	14	as	as	ADP
dpc-1605	34	15	in	in	ADP
dpc-1605	34	16	tumescent	tumescent	NOUN
dpc-1605	34	17	anesthesia	anesthesia	PROPN
dpc-1605	34	18	(	(	PUNCT
dpc-1605	34	19	increased	increase	VERB
dpc-1605	34	20	local	local	ADJ
dpc-1605	34	21	hydrostatic	hydrostatic	ADJ
dpc-1605	34	22	pressure	pressure	NOUN
dpc-1605	34	23	)	)	PUNCT
dpc-1605	34	24	,	,	PUNCT
dpc-1605	34	25	slows	slow	VERB
dpc-1605	34	26	lidocaine	lidocaine	NOUN
dpc-1605	34	27	uptake	uptake	ADJ
dpc-1605	34	28	with	with	ADP
dpc-1605	34	29	resulting	result	VERB
dpc-1605	34	30	increased	increase	VERB
dpc-1605	34	31	half	half	ADJ
dpc-1605	34	32	-	-	PUNCT
dpc-1605	34	33	life	life	NOUN
dpc-1605	34	34	and	and	CCONJ
dpc-1605	34	35	lower	low	ADJ
dpc-1605	34	36	peak	peak	NOUN
dpc-1605	34	37	plasma	plasma	NOUN
dpc-1605	34	38	levels	level	NOUN
dpc-1605	34	39	,	,	PUNCT
dpc-1605	34	40	that	that	PRON
dpc-1605	34	41	permit	permit	VERB
dpc-1605	34	42	a	a	DET
dpc-1605	34	43	higher	high	ADJ
dpc-1605	34	44	maximum	maximum	NOUN
dpc-1605	34	45	dose	dose	NOUN
dpc-1605	34	46	to	to	PART
dpc-1605	34	47	be	be	AUX
dpc-1605	34	48	administered	administer	VERB
dpc-1605	34	49	[	[	X
dpc-1605	34	50	1,4,6	1,4,6	NUM
dpc-1605	34	51	]	]	PUNCT
dpc-1605	34	52	.	.	PUNCT
dpc-1605	35	1	lidocaine	lidocaine	PROPN
dpc-1605	35	2	is	be	AUX
dpc-1605	35	3	lipophilic	lipophilic	ADJ
dpc-1605	35	4	and	and	CCONJ
dpc-1605	35	5	slower	slow	ADJ
dpc-1605	35	6	absorption	absorption	NOUN
dpc-1605	35	7	allows	allow	VERB
dpc-1605	35	8	a	a	DET
dpc-1605	35	9	depot	depot	NOUN
dpc-1605	35	10	-	-	PUNCT
dpc-1605	35	11	like	like	ADJ
dpc-1605	35	12	effect	effect	NOUN
dpc-1605	35	13	[	[	X
dpc-1605	35	14	4	4	NUM
dpc-1605	35	15	]	]	PUNCT
dpc-1605	35	16	.	.	PUNCT
dpc-1605	36	1	ramon	ramon	NOUN
dpc-1605	36	2	et	et	PROPN
dpc-1605	36	3	al	al	PROPN
dpc-1605	36	4	studied	study	VERB
dpc-1605	36	5	the	the	DET
dpc-1605	36	6	combination	combination	NOUN
dpc-1605	36	7	of	of	ADP
dpc-1605	36	8	epinephrine	epinephrine	NOUN
dpc-1605	36	9	and	and	CCONJ
dpc-1605	36	10	dilute	dilute	VERB
dpc-1605	36	11	lidocaine	lidocaine	NOUN
dpc-1605	36	12	(	(	PUNCT
dpc-1605	36	13	0.33	0.33	NUM
dpc-1605	36	14	%	%	NOUN
dpc-1605	36	15	)	)	PUNCT
dpc-1605	36	16	in	in	ADP
dpc-1605	36	17	patients	patient	NOUN
dpc-1605	36	18	undergoing	undergo	VERB
dpc-1605	36	19	facelift	facelift	NOUN
dpc-1605	36	20	surgery	surgery	NOUN
dpc-1605	36	21	.	.	PUNCT
dpc-1605	37	1	the	the	DET
dpc-1605	37	2	half	half	ADJ
dpc-1605	37	3	-	-	PUNCT
dpc-1605	37	4	life	life	NOUN
dpc-1605	37	5	of	of	ADP
dpc-1605	37	6	lidocaine	lidocaine	NOUN
dpc-1605	37	7	was	be	AUX
dpc-1605	37	8	found	find	VERB
dpc-1605	37	9	to	to	PART
dpc-1605	37	10	be	be	AUX
dpc-1605	37	11	increased	increase	VERB
dpc-1605	37	12	to	to	ADP
dpc-1605	37	13	6	6	NUM
dpc-1605	37	14	hours	hour	NOUN
dpc-1605	37	15	(	(	PUNCT
dpc-1605	37	16	compared	compare	VERB
dpc-1605	37	17	with	with	ADP
dpc-1605	37	18	2	2	NUM
dpc-1605	37	19	hours	hour	NOUN
dpc-1605	37	20	for	for	ADP
dpc-1605	37	21	intravenous	intravenous	ADJ
dpc-1605	37	22	lidocaine	lidocaine	NOUN
dpc-1605	37	23	)	)	PUNCT
dpc-1605	37	24	when	when	SCONJ
dpc-1605	37	25	used	use	VERB
dpc-1605	37	26	together	together	ADV
dpc-1605	37	27	with	with	ADP
dpc-1605	37	28	epinephrine	epinephrine	NOUN
dpc-1605	37	29	[	[	X
dpc-1605	37	30	6	6	NUM
dpc-1605	37	31	]	]	PUNCT
dpc-1605	37	32	.	.	PUNCT
dpc-1605	38	1	in	in	ADP
dpc-1605	38	2	addition	addition	NOUN
dpc-1605	38	3	,	,	PUNCT
dpc-1605	38	4	researchers	researcher	NOUN
dpc-1605	38	5	were	be	AUX
dpc-1605	38	6	able	able	ADJ
dpc-1605	38	7	to	to	PART
dpc-1605	38	8	safely	safely	ADV
dpc-1605	38	9	use	use	VERB
dpc-1605	38	10	3	3	NUM
dpc-1605	38	11	times	time	NOUN
dpc-1605	38	12	the	the	DET
dpc-1605	38	13	threshold	threshold	NOUN
dpc-1605	38	14	limit	limit	NOUN
dpc-1605	38	15	of	of	ADP
dpc-1605	38	16	maximum	maximum	ADJ
dpc-1605	38	17	recommended	recommend	VERB
dpc-1605	38	18	lidocaine	lidocaine	NOUN
dpc-1605	38	19	doses	dose	NOUN
dpc-1605	38	20	(	(	PUNCT
dpc-1605	38	21	17	17	NUM
dpc-1605	38	22	to	to	PART
dpc-1605	38	23	26	26	NUM
dpc-1605	38	24	mg	mg	NUM
dpc-1605	38	25	/	/	SYM
dpc-1605	38	26	kg	kg	PROPN
dpc-1605	38	27	of	of	ADP
dpc-1605	38	28	lidocaine	lidocaine	NOUN
dpc-1605	38	29	)	)	PUNCT
dpc-1605	38	30	.	.	PUNCT
dpc-1605	39	1	despite	despite	SCONJ
dpc-1605	39	2	the	the	DET
dpc-1605	39	3	much	much	ADV
dpc-1605	39	4	higher	high	ADJ
dpc-1605	39	5	doses	dose	NOUN
dpc-1605	39	6	used	use	VERB
dpc-1605	39	7	,	,	PUNCT
dpc-1605	39	8	the	the	DET
dpc-1605	39	9	maximum	maximum	ADJ
dpc-1605	39	10	lidocaine	lidocaine	NOUN
dpc-1605	39	11	plasma	plasma	NOUN
dpc-1605	39	12	concentration	concentration	NOUN
dpc-1605	39	13	remained	remain	VERB
dpc-1605	39	14	well	well	ADV
dpc-1605	39	15	below	below	ADP
dpc-1605	39	16	the	the	DET
dpc-1605	39	17	toxic	toxic	ADJ
dpc-1605	39	18	range	range	NOUN
dpc-1605	39	19	(	(	PUNCT
dpc-1605	39	20	1.14	1.14	NUM
dpc-1605	39	21	to	to	PART
dpc-1605	39	22	2.2	2.2	NUM
dpc-1605	39	23	µg	µg	NOUN
dpc-1605	39	24	/	/	SYM
dpc-1605	39	25	ml	ml	NOUN
dpc-1605	39	26	)	)	PUNCT
dpc-1605	39	27	and	and	CCONJ
dpc-1605	39	28	no	no	DET
dpc-1605	39	29	adverse	adverse	ADJ
dpc-1605	39	30	effects	effect	NOUN
dpc-1605	39	31	were	be	AUX
dpc-1605	39	32	noted	note	VERB
dpc-1605	39	33	[	[	X
dpc-1605	39	34	6	6	NUM
dpc-1605	39	35	]	]	PUNCT
dpc-1605	39	36	.	.	PUNCT
dpc-1605	40	1	similarly	similarly	ADV
dpc-1605	40	2	,	,	PUNCT
dpc-1605	40	3	doses	dose	VERB
dpc-1605	40	4	up	up	ADV
dpc-1605	40	5	to	to	ADP
dpc-1605	40	6	55mg	55mg	ADV
dpc-1605	40	7	/	/	SYM
dpc-1605	40	8	kg	kg	NOUN
dpc-1605	40	9	have	have	AUX
dpc-1605	40	10	been	be	AUX
dpc-1605	40	11	administered	administer	VERB
dpc-1605	40	12	safely	safely	ADV
dpc-1605	40	13	with	with	ADP
dpc-1605	40	14	tumescent	tumescent	NOUN
dpc-1605	40	15	anesthesia	anesthesia	NOUN
dpc-1605	41	1	[	[	X
dpc-1605	41	2	7	7	NUM
dpc-1605	41	3	]	]	PUNCT
dpc-1605	41	4	.	.	PUNCT
dpc-1605	42	1	the	the	DET
dpc-1605	42	2	clinical	clinical	ADJ
dpc-1605	42	3	features	feature	NOUN
dpc-1605	42	4	of	of	ADP
dpc-1605	42	5	lidocaine	lidocaine	NOUN
dpc-1605	42	6	overdose	overdose	NOUN
dpc-1605	42	7	depend	depend	VERB
dpc-1605	42	8	on	on	ADP
dpc-1605	42	9	serum	serum	NOUN
dpc-1605	42	10	concentration	concentration	NOUN
dpc-1605	42	11	and	and	CCONJ
dpc-1605	42	12	different	different	ADJ
dpc-1605	42	13	sources	source	NOUN
dpc-1605	42	14	cite	cite	VERB
dpc-1605	42	15	varying	vary	VERB
dpc-1605	42	16	serum	serum	NOUN
dpc-1605	42	17	concentrations	concentration	NOUN
dpc-1605	42	18	at	at	ADP
dpc-1605	42	19	which	which	PRON
dpc-1605	42	20	toxicity	toxicity	NOUN
dpc-1605	42	21	is	be	AUX
dpc-1605	42	22	first	first	ADV
dpc-1605	42	23	observed	observe	VERB
dpc-1605	42	24	[	[	X
dpc-1605	42	25	3,4,6,8	3,4,6,8	NUM
dpc-1605	42	26	]	]	X
dpc-1605	42	27	.	.	PUNCT
dpc-1605	43	1	mild	mild	ADJ
dpc-1605	43	2	symptoms	symptom	NOUN
dpc-1605	43	3	are	be	AUX
dpc-1605	43	4	reported	report	VERB
dpc-1605	43	5	to	to	PART
dpc-1605	43	6	occur	occur	VERB
dpc-1605	43	7	above	above	ADP
dpc-1605	43	8	5µg	5µg	NOUN
dpc-1605	43	9	/	/	SYM
dpc-1605	43	10	ml	ml	VERB
dpc-1605	43	11	.	.	PUNCT
dpc-1605	44	1	these	these	PRON
dpc-1605	44	2	include	include	VERB
dpc-1605	44	3	dizziness	dizziness	NOUN
dpc-1605	44	4	,	,	PUNCT
dpc-1605	44	5	lightheadedness	lightheadedness	NOUN
dpc-1605	44	6	,	,	PUNCT
dpc-1605	44	7	and	and	CCONJ
dpc-1605	44	8	circumoral	circumoral	ADJ
dpc-1605	44	9	paresthesias	paresthesia	NOUN
dpc-1605	44	10	for	for	ADP
dpc-1605	44	11	which	which	DET
dpc-1605	44	12	observation	observation	NOUN
dpc-1605	44	13	is	be	AUX
dpc-1605	44	14	recommended	recommend	VERB
dpc-1605	44	15	.	.	PUNCT
dpc-1605	45	1	neurologic	neurologic	ADJ
dpc-1605	45	2	and	and	CCONJ
dpc-1605	45	3	cardiopulmonary	cardiopulmonary	ADJ
dpc-1605	45	4	complications	complication	NOUN
dpc-1605	45	5	such	such	ADJ
dpc-1605	45	6	as	as	ADP
dpc-1605	45	7	seizures	seizure	NOUN
dpc-1605	45	8	,	,	PUNCT
dpc-1605	45	9	cardiac	cardiac	ADJ
dpc-1605	45	10	and	and	CCONJ
dpc-1605	45	11	respiratory	respiratory	ADJ
dpc-1605	45	12	arrest	arrest	NOUN
dpc-1605	45	13	may	may	AUX
dpc-1605	45	14	occur	occur	VERB
dpc-1605	45	15	between	between	ADP
dpc-1605	45	16	doses	dose	NOUN
dpc-1605	45	17	of	of	ADP
dpc-1605	45	18	9	9	NUM
dpc-1605	45	19	to	to	PART
dpc-1605	45	20	20µg/	20µg/	NUM
dpc-1605	45	21	ml	ml	NOUN
dpc-1605	45	22	–	–	PUNCT
dpc-1605	45	23	in	in	ADP
dpc-1605	45	24	these	these	DET
dpc-1605	45	25	cases	case	NOUN
dpc-1605	45	26	,	,	PUNCT
dpc-1605	45	27	there	there	PRON
dpc-1605	45	28	is	be	VERB
dpc-1605	45	29	the	the	DET
dpc-1605	45	30	need	need	NOUN
dpc-1605	45	31	for	for	ADP
dpc-1605	45	32	an	an	DET
dpc-1605	45	33	emergency	emergency	NOUN
dpc-1605	45	34	management	management	NOUN
dpc-1605	45	35	with	with	ADP
dpc-1605	45	36	oxygen	oxygen	NOUN
dpc-1605	45	37	supplementation	supplementation	NOUN
dpc-1605	45	38	and	and	CCONJ
dpc-1605	45	39	administration	administration	NOUN
dpc-1605	45	40	of	of	ADP
dpc-1605	45	41	benzodiazepines	benzodiazepine	NOUN
dpc-1605	45	42	(	(	PUNCT
dpc-1605	45	43	with	with	ADP
dpc-1605	45	44	or	or	CCONJ
dpc-1605	45	45	without	without	ADP
dpc-1605	45	46	intravenous	intravenous	ADJ
dpc-1605	45	47	lipid	lipid	NOUN
dpc-1605	45	48	emulsion	emulsion	NOUN
dpc-1605	45	49	)	)	PUNCT
dpc-1605	46	1	[	[	X
dpc-1605	46	2	3,4,6,8,9	3,4,6,8,9	NOUN
dpc-1605	46	3	]	]	PUNCT
dpc-1605	46	4	.	.	PUNCT
dpc-1605	47	1	in	in	ADP
dpc-1605	47	2	dermatologic	dermatologic	ADJ
dpc-1605	47	3	surgery	surgery	NOUN
dpc-1605	47	4	,	,	PUNCT
dpc-1605	47	5	lidocaine	lidocaine	NOUN
dpc-1605	47	6	associated	associate	VERB
dpc-1605	47	7	systemic	systemic	ADJ
dpc-1605	47	8	toxicity	toxicity	NOUN
dpc-1605	47	9	(	(	PUNCT
dpc-1605	47	10	last	last	ADJ
dpc-1605	47	11	)	)	PUNCT
dpc-1605	47	12	events	event	NOUN
dpc-1605	47	13	are	be	AUX
dpc-1605	47	14	infrequent	infrequent	ADJ
dpc-1605	47	15	.	.	PUNCT
dpc-1605	48	1	in	in	ADP
dpc-1605	48	2	a	a	DET
dpc-1605	48	3	review	review	NOUN
dpc-1605	48	4	of	of	ADP
dpc-1605	48	5	last	last	ADJ
dpc-1605	48	6	data	datum	NOUN
dpc-1605	48	7	from	from	ADP
dpc-1605	48	8	2010	2010	NUM
dpc-1605	48	9	to	to	ADP
dpc-1605	48	10	2014	2014	NUM
dpc-1605	48	11	,	,	PUNCT
dpc-1605	48	12	only	only	ADV
dpc-1605	48	13	2	2	NUM
dpc-1605	48	14	of	of	ADP
dpc-1605	48	15	67	67	NUM
dpc-1605	48	16	cases	case	NOUN
dpc-1605	48	17	were	be	AUX
dpc-1605	48	18	dermatologist	dermatologist	NOUN
dpc-1605	48	19	performed	perform	VERB
dpc-1605	48	20	procedures	procedure	NOUN
dpc-1605	48	21	,	,	PUNCT
dpc-1605	48	22	both	both	CCONJ
dpc-1605	48	23	after	after	ADP
dpc-1605	48	24	topical	topical	ADJ
dpc-1605	48	25	lidocaine	lidocaine	NOUN
dpc-1605	48	26	/	/	SYM
dpc-1605	48	27	prilocaine	prilocaine	NOUN
dpc-1605	48	28	application	application	NOUN
dpc-1605	48	29	[	[	X
dpc-1605	48	30	10	10	NUM
dpc-1605	48	31	]	]	PUNCT
dpc-1605	48	32	.	.	PUNCT
dpc-1605	49	1	based	base	VERB
dpc-1605	49	2	on	on	ADP
dpc-1605	49	3	a	a	DET
dpc-1605	49	4	mandatory	mandatory	ADJ
dpc-1605	49	5	adverse	adverse	ADJ
dpc-1605	49	6	-	-	PUNCT
dpc-1605	49	7	event	event	NOUN
dpc-1605	49	8	data	datum	NOUN
dpc-1605	49	9	of	of	ADP
dpc-1605	49	10	office	office	NOUN
dpc-1605	49	11	-	-	PUNCT
dpc-1605	49	12	based	base	VERB
dpc-1605	49	13	surgery	surgery	NOUN
dpc-1605	49	14	in	in	ADP
dpc-1605	49	15	florida	florida	PROPN
dpc-1605	49	16	and	and	CCONJ
dpc-1605	49	17	alabama	alabama	PROPN
dpc-1605	49	18	,	,	PUNCT
dpc-1605	49	19	only	only	ADV
dpc-1605	49	20	4	4	NUM
dpc-1605	49	21	dermatologist	dermatologist	NOUN
dpc-1605	49	22	associated	associated	ADJ
dpc-1605	49	23	complications	complication	NOUN
dpc-1605	49	24	were	be	AUX
dpc-1605	49	25	reported	report	VERB
dpc-1605	49	26	over	over	ADP
dpc-1605	49	27	10	10	NUM
dpc-1605	49	28	years	year	NOUN
dpc-1605	49	29	and	and	CCONJ
dpc-1605	49	30	1	1	NUM
dpc-1605	49	31	complication	complication	NOUN
dpc-1605	49	32	over	over	ADP
dpc-1605	49	33	6	6	NUM
dpc-1605	49	34	years	year	NOUN
dpc-1605	49	35	,	,	PUNCT
dpc-1605	49	36	respectively	respectively	ADV
dpc-1605	49	37	[	[	X
dpc-1605	49	38	11	11	NUM
dpc-1605	49	39	]	]	PUNCT
dpc-1605	49	40	.	.	PUNCT
dpc-1605	50	1	3	3	NUM
dpc-1605	50	2	of	of	ADP
dpc-1605	50	3	these	these	DET
dpc-1605	50	4	5	5	NUM
dpc-1605	50	5	were	be	AUX
dpc-1605	50	6	associated	associate	VERB
dpc-1605	50	7	with	with	ADP
dpc-1605	50	8	lidocaine	lidocaine	NOUN
dpc-1605	50	9	infiltration	infiltration	NOUN
dpc-1605	50	10	:	:	PUNCT
dpc-1605	50	11	the	the	DET
dpc-1605	50	12	first	first	ADJ
dpc-1605	50	13	was	be	AUX
dpc-1605	50	14	transient	transient	ADJ
dpc-1605	50	15	atrial	atrial	ADJ
dpc-1605	50	16	fibrillation	fibrillation	NOUN
dpc-1605	50	17	2	2	NUM
dpc-1605	50	18	hours	hour	NOUN
dpc-1605	50	19	after	after	SCONJ
dpc-1605	50	20	an	an	DET
dpc-1605	50	21	excision	excision	NOUN
dpc-1605	50	22	performed	perform	VERB
dpc-1605	50	23	with	with	ADP
dpc-1605	50	24	minimal	minimal	ADJ
dpc-1605	50	25	local	local	ADJ
dpc-1605	50	26	lidocaine	lidocaine	NOUN
dpc-1605	50	27	,	,	PUNCT
dpc-1605	50	28	another	another	PRON
dpc-1605	50	29	was	be	AUX
dpc-1605	50	30	a	a	DET
dpc-1605	50	31	wrong	wrong	ADJ
dpc-1605	50	32	surgical	surgical	ADJ
dpc-1605	50	33	site	site	NOUN
dpc-1605	50	34	during	during	ADP
dpc-1605	50	35	a	a	DET
dpc-1605	50	36	mohs	mohs	NOUN
dpc-1605	50	37	procedure	procedure	NOUN
dpc-1605	50	38	,	,	PUNCT
dpc-1605	50	39	and	and	CCONJ
dpc-1605	50	40	lastly	lastly	ADV
dpc-1605	50	41	,	,	PUNCT
dpc-1605	50	42	a	a	DET
dpc-1605	50	43	post	post	ADJ
dpc-1605	50	44	-	-	ADJ
dpc-1605	50	45	excision	excision	ADJ
dpc-1605	50	46	infection	infection	NOUN
dpc-1605	50	47	with	with	ADP
dpc-1605	50	48	staphylococcus	staphylococcus	NOUN
dpc-1605	50	49	[	[	X
dpc-1605	50	50	10	10	NUM
dpc-1605	50	51	]	]	PUNCT
dpc-1605	50	52	.	.	PUNCT
dpc-1605	51	1	additionally	additionally	ADV
dpc-1605	51	2	,	,	PUNCT
dpc-1605	51	3	alam	alam	PROPN
dpc-1605	51	4	et	et	PROPN
dpc-1605	51	5	al	al	PROPN
dpc-1605	51	6	sought	seek	VERB
dpc-1605	51	7	to	to	PART
dpc-1605	51	8	determine	determine	VERB
dpc-1605	51	9	if	if	SCONJ
dpc-1605	51	10	lidocaine	lidocaine	ADJ
dpc-1605	51	11	injection	injection	NOUN
dpc-1605	51	12	in	in	ADP
dpc-1605	51	13	the	the	DET
dpc-1605	51	14	head	head	NOUN
dpc-1605	51	15	and	and	CCONJ
dpc-1605	51	16	neck	neck	NOUN
dpc-1605	51	17	led	lead	VERB
dpc-1605	51	18	to	to	ADP
dpc-1605	51	19	higher	high	ADJ
dpc-1605	51	20	absorption	absorption	NOUN
dpc-1605	51	21	.	.	PUNCT
dpc-1605	52	1	despite	despite	SCONJ
dpc-1605	52	2	using	use	VERB
dpc-1605	52	3	48	48	NUM
dpc-1605	52	4	mls	mls	NOUN
dpc-1605	52	5	of	of	ADP
dpc-1605	52	6	1	1	NUM
dpc-1605	52	7	%	%	NOUN
dpc-1605	52	8	lidocaine	lidocaine	NOUN
dpc-1605	52	9	with	with	ADP
dpc-1605	52	10	1:100,000	1:100,000	NUM
dpc-1605	52	11	epinephrine	epinephrine	NOUN
dpc-1605	52	12	,	,	PUNCT
dpc-1605	52	13	the	the	DET
dpc-1605	52	14	highest	highest	ADV
dpc-1605	52	15	recorded	record	VERB
dpc-1605	52	16	serum	serum	NOUN
dpc-1605	52	17	level	level	NOUN
dpc-1605	52	18	in	in	ADP
dpc-1605	52	19	this	this	DET
dpc-1605	52	20	study	study	NOUN
dpc-1605	52	21	was	be	AUX
dpc-1605	52	22	0.3	0.3	NUM
dpc-1605	52	23	µg	µg	NOUN
dpc-1605	52	24	/	/	SYM
dpc-1605	52	25	ml	ml	NOUN
dpc-1605	53	1	[	[	X
dpc-1605	53	2	3	3	NUM
dpc-1605	53	3	]	]	PUNCT
dpc-1605	53	4	.	.	PUNCT
dpc-1605	54	1	a	a	DET
dpc-1605	54	2	blanket	blanket	NOUN
dpc-1605	54	3	cap	cap	NOUN
dpc-1605	54	4	on	on	ADP
dpc-1605	54	5	maximum	maximum	ADJ
dpc-1605	54	6	lidocaine	lidocaine	NOUN
dpc-1605	54	7	dose	dose	NOUN
dpc-1605	54	8	in	in	ADP
dpc-1605	54	9	dermatologic	dermatologic	ADJ
dpc-1605	54	10	surgery	surgery	NOUN
dpc-1605	54	11	is	be	AUX
dpc-1605	54	12	not	not	PART
dpc-1605	54	13	scientifically	scientifically	ADV
dpc-1605	54	14	valid	valid	ADJ
dpc-1605	54	15	.	.	PUNCT
dpc-1605	55	1	although	although	SCONJ
dpc-1605	55	2	simple	simple	ADJ
dpc-1605	55	3	procedures	procedure	NOUN
dpc-1605	55	4	rarely	rarely	ADV
dpc-1605	55	5	require	require	VERB
dpc-1605	55	6	these	these	DET
dpc-1605	55	7	high	high	ADJ
dpc-1605	55	8	doses	dose	NOUN
dpc-1605	55	9	,	,	PUNCT
dpc-1605	55	10	procedures	procedure	NOUN
dpc-1605	55	11	such	such	ADJ
dpc-1605	55	12	as	as	ADP
dpc-1605	55	13	mohs	mohs	PROPN
dpc-1605	55	14	surgery	surgery	NOUN
dpc-1605	55	15	often	often	ADV
dpc-1605	55	16	require	require	VERB
dpc-1605	55	17	stacking	stacking	NOUN
dpc-1605	55	18	of	of	ADP
dpc-1605	55	19	local	local	ADJ
dpc-1605	55	20	anesthesia	anesthesia	NOUN
dpc-1605	55	21	given	give	VERB
dpc-1605	55	22	the	the	DET
dpc-1605	55	23	multiple	multiple	ADJ
dpc-1605	55	24	layers	layer	NOUN
dpc-1605	55	25	and	and	CCONJ
dpc-1605	55	26	the	the	DET
dpc-1605	55	27	larger	large	ADJ
dpc-1605	55	28	areas	area	NOUN
dpc-1605	55	29	requiring	require	VERB
dpc-1605	55	30	anesthesia	anesthesia	NOUN
dpc-1605	55	31	for	for	ADP
dpc-1605	55	32	closure	closure	NOUN
dpc-1605	55	33	.	.	PUNCT
dpc-1605	56	1	in	in	ADP
dpc-1605	56	2	addition	addition	NOUN
dpc-1605	56	3	,	,	PUNCT
dpc-1605	56	4	various	various	ADJ
dpc-1605	56	5	patient	patient	ADJ
dpc-1605	56	6	factors	factor	NOUN
dpc-1605	56	7	such	such	ADJ
dpc-1605	56	8	as	as	ADP
dpc-1605	56	9	height	height	NOUN
dpc-1605	56	10	,	,	PUNCT
dpc-1605	56	11	weight	weight	NOUN
dpc-1605	56	12	,	,	PUNCT
dpc-1605	56	13	race	race	NOUN
dpc-1605	56	14	,	,	PUNCT
dpc-1605	56	15	medical	medical	ADJ
dpc-1605	56	16	problems	problem	NOUN
dpc-1605	56	17	should	should	AUX
dpc-1605	56	18	be	be	AUX
dpc-1605	56	19	considered	consider	VERB
dpc-1605	56	20	in	in	ADP
dpc-1605	56	21	future	future	ADJ
dpc-1605	56	22	studies	study	NOUN
dpc-1605	56	23	.	.	PUNCT
dpc-1605	57	1	when	when	SCONJ
dpc-1605	57	2	preparing	prepare	VERB
dpc-1605	57	3	for	for	ADP
dpc-1605	57	4	dermatologic	dermatologic	ADJ
dpc-1605	57	5	surgery	surgery	NOUN
dpc-1605	57	6	,	,	PUNCT
dpc-1605	57	7	it	it	PRON
dpc-1605	57	8	would	would	AUX
dpc-1605	57	9	be	be	AUX
dpc-1605	57	10	beneficial	beneficial	ADJ
dpc-1605	57	11	to	to	PART
dpc-1605	57	12	emphasize	emphasize	VERB
dpc-1605	57	13	appropriate	appropriate	ADJ
dpc-1605	57	14	anesthetic	anesthetic	ADJ
dpc-1605	57	15	technique	technique	NOUN
dpc-1605	57	16	to	to	PART
dpc-1605	57	17	ensure	ensure	VERB
dpc-1605	57	18	prevention	prevention	NOUN
dpc-1605	57	19	of	of	ADP
dpc-1605	57	20	intra	intra	ADJ
dpc-1605	57	21	-	-	ADJ
dpc-1605	57	22	arterial	arterial	ADJ
dpc-1605	57	23	injection	injection	NOUN
dpc-1605	57	24	and	and	CCONJ
dpc-1605	57	25	confirm	confirm	VERB
dpc-1605	57	26	the	the	DET
dpc-1605	57	27	absence	absence	NOUN
dpc-1605	57	28	of	of	ADP
dpc-1605	57	29	liver	liver	NOUN
dpc-1605	57	30	disease	disease	NOUN
dpc-1605	57	31	and/or	and/or	CCONJ
dpc-1605	57	32	drugs	drug	NOUN
dpc-1605	57	33	that	that	PRON
dpc-1605	57	34	may	may	AUX
dpc-1605	57	35	complicate	complicate	VERB
dpc-1605	57	36	lidocaine	lidocaine	NOUN
dpc-1605	57	37	elimination	elimination	NOUN
dpc-1605	57	38	when	when	SCONJ
dpc-1605	57	39	screening	screen	VERB
dpc-1605	57	40	patients	patient	NOUN
dpc-1605	57	41	for	for	ADP
dpc-1605	57	42	procedures	procedure	NOUN
dpc-1605	57	43	.	.	PUNCT
dpc-1605	58	1	references	reference	NOUN
dpc-1605	58	2	1	1	NUM
dpc-1605	58	3	.	.	PUNCT
dpc-1605	59	1	rosenberg	rosenberg	PROPN
dpc-1605	59	2	ph	ph	PROPN
dpc-1605	59	3	,	,	PUNCT
dpc-1605	59	4	veering	veer	VERB
dpc-1605	59	5	bt	bt	NOUN
dpc-1605	59	6	,	,	PUNCT
dpc-1605	59	7	urmey	urmey	ADJ
dpc-1605	59	8	wf	wf	PROPN
dpc-1605	59	9	.	.	PUNCT
dpc-1605	60	1	maximum	maximum	ADJ
dpc-1605	60	2	recommended	recommend	VERB
dpc-1605	60	3	doses	dose	NOUN
dpc-1605	60	4	of	of	ADP
dpc-1605	60	5	local	local	ADJ
dpc-1605	60	6	anesthetics	anesthetic	NOUN
dpc-1605	60	7	:	:	PUNCT
dpc-1605	60	8	a	a	DET
dpc-1605	60	9	multifactorial	multifactorial	ADJ
dpc-1605	60	10	concept	concept	NOUN
dpc-1605	60	11	.	.	PUNCT
dpc-1605	61	1	reg	reg	NOUN
dpc-1605	61	2	anesth	anesth	PROPN
dpc-1605	61	3	pain	pain	NOUN
dpc-1605	61	4	med	me	VERB
dpc-1605	61	5	.	.	PUNCT
dpc-1605	62	1	2004;29(6):564	2004;29(6):564	NUM
dpc-1605	62	2	-	-	SYM
dpc-1605	62	3	575	575	NUM
dpc-1605	62	4	.	.	PUNCT
dpc-1605	63	1	doi	doi	NOUN
dpc-1605	63	2	:	:	PUNCT
dpc-1605	63	3	10.1016	10.1016	NUM
dpc-1605	63	4	/	/	SYM
dpc-1605	63	5	j.	j.	PROPN
dpc-1605	63	6	rapm.2004.08.003	rapm.2004.08.003	PROPN
dpc-1605	63	7	.	.	PROPN
dpc-1605	64	1	pmid	pmid	PROPN
dpc-1605	64	2	:	:	PUNCT
dpc-1605	64	3	15635516	15635516	NUM
dpc-1605	64	4	.	.	PUNCT
dpc-1605	65	1	pmid	pmid	NOUN
dpc-1605	65	2	:	:	PUNCT
dpc-1605	65	3	18101361	18101361	NUM
dpc-1605	65	4	.	.	X
dpc-1605	66	1	2	2	X
dpc-1605	66	2	.	.	X
dpc-1605	66	3	gordh	gordh	PROPN
dpc-1605	66	4	t.	t.	PROPN
dpc-1605	66	5	xylocain	xylocain	PROPN
dpc-1605	66	6	,	,	PUNCT
dpc-1605	66	7	a	a	DET
dpc-1605	66	8	new	new	ADJ
dpc-1605	66	9	local	local	ADJ
dpc-1605	66	10	analgesic	analgesic	NOUN
dpc-1605	66	11	.	.	PUNCT
dpc-1605	67	1	anaesthesia	anaesthesia	NOUN
dpc-1605	67	2	.	.	PUNCT
dpc-1605	68	1	1949;4(1):4	1949;4(1):4	NOUN
dpc-1605	68	2	-	-	PUNCT
dpc-1605	68	3	9	9	NUM
dpc-1605	68	4	.	.	PUNCT
dpc-1605	68	5	doi	doi	NOUN
dpc-1605	68	6	:	:	PUNCT
dpc-1605	68	7	10.1111	10.1111	NUM
dpc-1605	68	8	/	/	SYM
dpc-1605	68	9	j.1365	j.1365	NOUN
dpc-1605	68	10	-	-	PUNCT
dpc-1605	68	11	2044.1949.tb05802.x	2044.1949.tb05802.x	NUM
dpc-1605	68	12	.	.	PUNCT
dpc-1605	69	1	pmid	pmid	NOUN
dpc-1605	69	2	:	:	PUNCT
dpc-1605	69	3	18101361	18101361	NUM
dpc-1605	69	4	3	3	X
dpc-1605	69	5	.	.	PUNCT
dpc-1605	69	6	alam	alam	PROPN
dpc-1605	69	7	m	m	PROPN
dpc-1605	69	8	,	,	PUNCT
dpc-1605	69	9	ricci	ricci	PROPN
dpc-1605	69	10	d	d	PROPN
dpc-1605	69	11	,	,	PUNCT
dpc-1605	69	12	havey	havey	PROPN
dpc-1605	69	13	j	j	PROPN
dpc-1605	69	14	,	,	PUNCT
dpc-1605	69	15	rademaker	rademaker	VERB
dpc-1605	69	16	a	a	PRON
dpc-1605	69	17	,	,	PUNCT
dpc-1605	69	18	witherspoon	witherspoon	PROPN
dpc-1605	69	19	j	j	PROPN
dpc-1605	69	20	,	,	PUNCT
dpc-1605	69	21	west	west	PROPN
dpc-1605	69	22	dp	dp	PROPN
dpc-1605	69	23	.	.	PUNCT
dpc-1605	69	24	safety	safety	NOUN
dpc-1605	69	25	of	of	ADP
dpc-1605	69	26	peak	peak	NOUN
dpc-1605	69	27	serum	serum	NOUN
dpc-1605	69	28	lidocaine	lidocaine	NOUN
dpc-1605	69	29	concentration	concentration	NOUN
dpc-1605	69	30	after	after	ADP
dpc-1605	69	31	mohs	mohs	PROPN
dpc-1605	69	32	micrographic	micrographic	ADJ
dpc-1605	69	33	surgery	surgery	NOUN
dpc-1605	69	34	:	:	PUNCT
dpc-1605	69	35	a	a	DET
dpc-1605	69	36	prospective	prospective	ADJ
dpc-1605	69	37	cohort	cohort	NOUN
dpc-1605	69	38	study	study	NOUN
dpc-1605	69	39	.	.	PUNCT
dpc-1605	70	1	j	j	PROPN
dpc-1605	70	2	am	be	AUX
dpc-1605	70	3	acad	acad	ADJ
dpc-1605	70	4	dermatol	dermatol	NOUN
dpc-1605	70	5	.	.	PUNCT
dpc-1605	71	1	2010;63(1):87	2010;63(1):87	NUM
dpc-1605	71	2	-	-	SYM
dpc-1605	71	3	92	92	NUM
dpc-1605	71	4	.	.	PUNCT
dpc-1605	72	1	doi	doi	NOUN
dpc-1605	72	2	:	:	PUNCT
dpc-1605	72	3	10.1016	10.1016	NUM
dpc-1605	72	4	/	/	SYM
dpc-1605	72	5	j.jaad.2009.08.046	j.jaad.2009.08.046	PROPN
dpc-1605	72	6	.	.	PUNCT
dpc-1605	73	1	pmid	pmid	NOUN
dpc-1605	73	2	:	:	PUNCT
dpc-1605	73	3	20462662	20462662	NUM
dpc-1605	73	4	4	4	NUM
dpc-1605	73	5	.	.	PUNCT
dpc-1605	73	6	lozinski	lozinski	PROPN
dpc-1605	73	7	a	a	X
dpc-1605	73	8	,	,	PUNCT
dpc-1605	73	9	huq	huq	PROPN
dpc-1605	73	10	ns	ns	PROPN
dpc-1605	73	11	.	.	PROPN
dpc-1605	73	12	tumescent	tumescent	NOUN
dpc-1605	73	13	liposuction	liposuction	PROPN
dpc-1605	73	14	.	.	PUNCT
dpc-1605	74	1	clin	clin	PROPN
dpc-1605	74	2	plast	plast	PROPN
dpc-1605	74	3	surg	surg	PROPN
dpc-1605	74	4	.	.	PUNCT
dpc-1605	75	1	2013;40(4):593	2013;40(4):593	NUM
dpc-1605	75	2	-	-	SYM
dpc-1605	75	3	613	613	NUM
dpc-1605	75	4	.	.	PUNCT
dpc-1605	75	5	doi	doi	NOUN
dpc-1605	75	6	:	:	PUNCT
dpc-1605	75	7	10.1016	10.1016	NUM
dpc-1605	75	8	/	/	SYM
dpc-1605	75	9	j.cps.2013.07.006	j.cps.2013.07.006	PROPN
dpc-1605	75	10	.	.	PUNCT
dpc-1605	76	1	pmid	pmid	NOUN
dpc-1605	76	2	:	:	PUNCT
dpc-1605	76	3	24093655	24093655	NUM
dpc-1605	76	4	.	.	PUNCT
dpc-1605	77	1	5	5	X
dpc-1605	77	2	.	.	X
dpc-1605	77	3	orlando	orlando	PROPN
dpc-1605	77	4	r	r	PROPN
dpc-1605	77	5	,	,	PUNCT
dpc-1605	77	6	piccoli	piccoli	NOUN
dpc-1605	77	7	p	p	X
dpc-1605	77	8	,	,	PUNCT
dpc-1605	77	9	de	de	PROPN
dpc-1605	77	10	martin	martin	PROPN
dpc-1605	77	11	s	s	PROPN
dpc-1605	77	12	,	,	PUNCT
dpc-1605	77	13	padrini	padrini	ADJ
dpc-1605	77	14	r	r	NOUN
dpc-1605	77	15	,	,	PUNCT
dpc-1605	77	16	palatini	palatini	NOUN
dpc-1605	77	17	p.	p.	NOUN
dpc-1605	77	18	effect	effect	NOUN
dpc-1605	77	19	of	of	ADP
dpc-1605	77	20	the	the	DET
dpc-1605	77	21	cyp3a4	cyp3a4	PROPN
dpc-1605	77	22	inhibitor	inhibitor	NOUN
dpc-1605	77	23	erythromycin	erythromycin	VERB
dpc-1605	77	24	on	on	ADP
dpc-1605	77	25	the	the	DET
dpc-1605	77	26	pharmacokinetics	pharmacokinetic	NOUN
dpc-1605	77	27	of	of	ADP
dpc-1605	77	28	lignocaine	lignocaine	NOUN
dpc-1605	77	29	and	and	CCONJ
dpc-1605	77	30	its	its	PRON
dpc-1605	77	31	pharmacologically	pharmacologically	ADV
dpc-1605	77	32	active	active	ADJ
dpc-1605	77	33	metabolites	metabolite	NOUN
dpc-1605	77	34	in	in	ADP
dpc-1605	77	35	subjects	subject	NOUN
dpc-1605	77	36	with	with	ADP
dpc-1605	77	37	normal	normal	ADJ
dpc-1605	77	38	and	and	CCONJ
dpc-1605	77	39	impaired	impaired	ADJ
dpc-1605	77	40	liver	liver	NOUN
dpc-1605	77	41	function	function	NOUN
dpc-1605	77	42	.	.	PUNCT
dpc-1605	78	1	br	br	PROPN
dpc-1605	79	1	j	j	PROPN
dpc-1605	79	2	clin	clin	PROPN
dpc-1605	79	3	pharmacol	pharmacol	PROPN
dpc-1605	79	4	.	.	PUNCT
dpc-1605	80	1	2003;55(1):86	2003;55(1):86	NUM
dpc-1605	80	2	-	-	SYM
dpc-1605	80	3	93	93	NUM
dpc-1605	80	4	.	.	PUNCT
dpc-1605	81	1	doi	doi	NOUN
dpc-1605	81	2	:	:	PUNCT
dpc-1605	81	3	10.1046	10.1046	NUM
dpc-1605	81	4	/	/	SYM
dpc-1605	81	5	j.1365	j.1365	NOUN
dpc-1605	81	6	-	-	PUNCT
dpc-1605	81	7	2125.2003.01718.x	2125.2003.01718.x	NUM
dpc-1605	81	8	.	.	PUNCT
dpc-1605	82	1	pmid	pmid	NOUN
dpc-1605	82	2	:	:	PUNCT
dpc-1605	82	3	125346446	125346446	NUM
dpc-1605	82	4	.	.	PUNCT
dpc-1605	83	1	6	6	NUM
dpc-1605	83	2	.	.	X
dpc-1605	83	3	ramon	ramon	PROPN
dpc-1605	83	4	y	y	PROPN
dpc-1605	83	5	,	,	PUNCT
dpc-1605	83	6	barak	barak	PROPN
dpc-1605	83	7	y	y	PROPN
dpc-1605	83	8	,	,	PUNCT
dpc-1605	83	9	ullmann	ullmann	PROPN
dpc-1605	83	10	y	y	PROPN
dpc-1605	83	11	,	,	PUNCT
dpc-1605	83	12	hoffer	hoffer	PROPN
dpc-1605	83	13	e	e	NOUN
dpc-1605	83	14	,	,	PUNCT
dpc-1605	83	15	yarhi	yarhi	PROPN
dpc-1605	83	16	d	d	NOUN
dpc-1605	83	17	,	,	PUNCT
dpc-1605	83	18	bentur	bentur	PROPN
dpc-1605	83	19	y.	y.	NOUN
dpc-1605	83	20	pharmacokinetics	pharmacokinetic	NOUN
dpc-1605	83	21	of	of	ADP
dpc-1605	83	22	high	high	ADV
dpc-1605	83	23	-	-	PUNCT
dpc-1605	83	24	dose	dose	NOUN
dpc-1605	83	25	diluted	dilute	VERB
dpc-1605	83	26	lidocaine	lidocaine	NOUN
dpc-1605	83	27	in	in	ADP
dpc-1605	83	28	local	local	ADJ
dpc-1605	83	29	anesthesia	anesthesia	NOUN
dpc-1605	83	30	for	for	ADP
dpc-1605	83	31	facelift	facelift	NOUN
dpc-1605	83	32	procedures	procedure	NOUN
dpc-1605	83	33	.	.	PUNCT
dpc-1605	84	1	ther	ther	PROPN
dpc-1605	84	2	drug	drug	PROPN
dpc-1605	84	3	monit	monit	NOUN
dpc-1605	84	4	.	.	PUNCT
dpc-1605	85	1	2007;29(5):644	2007;29(5):644	NUM
dpc-1605	85	2	-	-	SYM
dpc-1605	85	3	7	7	NUM
dpc-1605	85	4	.	.	PUNCT
dpc-1605	85	5	doi	doi	NOUN
dpc-1605	85	6	:	:	PUNCT
dpc-1605	85	7	10.1097	10.1097	NUM
dpc-1605	85	8	/	/	SYM
dpc-1605	85	9	ftd.0b013e3180eaa10a	ftd.0b013e3180eaa10a	NOUN
dpc-1605	85	10	.	.	PUNCT
dpc-1605	86	1	pmid	pmid	NOUN
dpc-1605	86	2	:	:	PUNCT
dpc-1605	86	3	17898657	17898657	NUM
dpc-1605	86	4	.	.	PUNCT
dpc-1605	87	1	7	7	X
dpc-1605	87	2	.	.	X
dpc-1605	87	3	ostad	ostad	PROPN
dpc-1605	87	4	a	a	PROPN
dpc-1605	87	5	,	,	PUNCT
dpc-1605	87	6	kageyama	kageyama	PROPN
dpc-1605	87	7	n	n	CCONJ
dpc-1605	87	8	,	,	PUNCT
dpc-1605	87	9	moy	moy	PROPN
dpc-1605	87	10	rl	rl	PROPN
dpc-1605	87	11	.	.	PUNCT
dpc-1605	87	12	tumescent	tumescent	NOUN
dpc-1605	87	13	anesthesia	anesthesia	PROPN
dpc-1605	87	14	with	with	ADP
dpc-1605	87	15	a	a	DET
dpc-1605	87	16	lidocaine	lidocaine	NOUN
dpc-1605	87	17	dose	dose	NOUN
dpc-1605	87	18	of	of	ADP
dpc-1605	87	19	55	55	NUM
dpc-1605	87	20	mg	mg	NOUN
dpc-1605	87	21	/	/	SYM
dpc-1605	87	22	kg	kg	PROPN
dpc-1605	87	23	is	be	AUX
dpc-1605	87	24	safe	safe	ADJ
dpc-1605	87	25	for	for	ADP
dpc-1605	87	26	liposuction	liposuction	NOUN
dpc-1605	87	27	.	.	PUNCT
dpc-1605	88	1	dermatol	dermatol	NOUN
dpc-1605	88	2	surg	surg	NOUN
dpc-1605	88	3	.	.	PUNCT
dpc-1605	89	1	1996;22(11):921	1996;22(11):921	NUM
dpc-1605	89	2	-	-	SYM
dpc-1605	89	3	7	7	NUM
dpc-1605	89	4	.	.	PUNCT
dpc-1605	89	5	doi	doi	NOUN
dpc-1605	89	6	:	:	PUNCT
dpc-1605	89	7	10.1111	10.1111	NUM
dpc-1605	89	8	/	/	SYM
dpc-1605	89	9	j.1524	j.1524	NOUN
dpc-1605	89	10	-	-	PUNCT
dpc-1605	89	11	4725.1996.tb00634.x	4725.1996.tb00634.x	PROPN
dpc-1605	89	12	.	.	PUNCT
dpc-1605	90	1	pmid	pmid	NOUN
dpc-1605	90	2	:	:	PUNCT
dpc-1605	90	3	9063507	9063507	NUM
dpc-1605	90	4	.	.	PUNCT
dpc-1605	91	1	8	8	NUM
dpc-1605	91	2	.	.	PUNCT
dpc-1605	91	3	minkis	minkis	PROPN
dpc-1605	91	4	k	k	PROPN
dpc-1605	91	5	,	,	PUNCT
dpc-1605	91	6	whittington	whittington	PROPN
dpc-1605	91	7	a	a	PROPN
dpc-1605	91	8	,	,	PUNCT
dpc-1605	91	9	alam	alam	PROPN
dpc-1605	91	10	m.	m.	NOUN
dpc-1605	91	11	dermatologic	dermatologic	ADJ
dpc-1605	91	12	surgery	surgery	NOUN
dpc-1605	91	13	emergencies	emergency	NOUN
dpc-1605	91	14	:	:	PUNCT
dpc-1605	91	15	complications	complication	NOUN
dpc-1605	91	16	caused	cause	VERB
dpc-1605	91	17	by	by	ADP
dpc-1605	91	18	systemic	systemic	ADJ
dpc-1605	91	19	reactions	reaction	NOUN
dpc-1605	91	20	,	,	PUNCT
dpc-1605	91	21	high	high	ADJ
dpc-1605	91	22	-	-	PUNCT
dpc-1605	91	23	energy	energy	NOUN
dpc-1605	91	24	systems	system	NOUN
dpc-1605	91	25	,	,	PUNCT
dpc-1605	91	26	and	and	CCONJ
dpc-1605	91	27	trauma	trauma	NOUN
dpc-1605	91	28	.	.	PUNCT
dpc-1605	92	1	j	j	PROPN
dpc-1605	92	2	am	be	AUX
dpc-1605	92	3	acad	acad	ADJ
dpc-1605	92	4	dermatol	dermatol	NOUN
dpc-1605	92	5	.	.	PUNCT
dpc-1605	93	1	2016;75(2):265	2016;75(2):265	NUM
dpc-1605	93	2	-	-	PUNCT
dpc-1605	93	3	84	84	NUM
dpc-1605	93	4	.	.	PUNCT
dpc-1605	94	1	doi	doi	NOUN
dpc-1605	94	2	:	:	PUNCT
dpc-1605	94	3	10.1016	10.1016	NUM
dpc-1605	94	4	/	/	SYM
dpc-1605	94	5	j.jaad.2015.11.054	j.jaad.2015.11.054	PROPN
dpc-1605	94	6	.	.	PUNCT
dpc-1605	95	1	pmid	pmid	NOUN
dpc-1605	95	2	:	:	PUNCT
dpc-1605	95	3	27444069	27444069	NUM
dpc-1605	95	4	.	.	PUNCT
dpc-1605	96	1	9	9	X
dpc-1605	96	2	.	.	X
dpc-1605	96	3	park	park	PROPN
dpc-1605	96	4	kk	kk	PROPN
dpc-1605	96	5	,	,	PUNCT
dpc-1605	96	6	sharon	sharon	PROPN
dpc-1605	96	7	vr	vr	PROPN
dpc-1605	96	8	.	.	PROPN
dpc-1605	97	1	a	a	DET
dpc-1605	97	2	review	review	NOUN
dpc-1605	97	3	of	of	ADP
dpc-1605	97	4	local	local	ADJ
dpc-1605	97	5	anesthetics	anesthetic	NOUN
dpc-1605	97	6	:	:	PUNCT
dpc-1605	97	7	minimizing	minimize	VERB
dpc-1605	97	8	risk	risk	NOUN
dpc-1605	97	9	and	and	CCONJ
dpc-1605	97	10	side	side	NOUN
dpc-1605	97	11	effects	effect	NOUN
dpc-1605	97	12	in	in	ADP
dpc-1605	97	13	cutaneous	cutaneous	ADJ
dpc-1605	97	14	surgery	surgery	NOUN
dpc-1605	97	15	.	.	PUNCT
dpc-1605	98	1	dermatol	dermatol	NOUN
dpc-1605	98	2	surg	surg	NOUN
dpc-1605	98	3	.	.	PUNCT
dpc-1605	99	1	2017;43(2):173	2017;43(2):173	NUM
dpc-1605	99	2	-	-	PUNCT
dpc-1605	99	3	187	187	NUM
dpc-1605	99	4	.	.	PUNCT
dpc-1605	100	1	doi	doi	NOUN
dpc-1605	100	2	:	:	PUNCT
dpc-1605	100	3	10.1097	10.1097	NUM
dpc-1605	100	4	/	/	SYM
dpc-1605	100	5	dss.0000000000000887	dss.0000000000000887	NUM
dpc-1605	100	6	.	.	PUNCT
dpc-1605	101	1	pmid	pmid	NOUN
dpc-1605	101	2	:	:	PUNCT
dpc-1605	101	3	27608208	27608208	NUM
dpc-1605	101	4	.	.	PUNCT
dpc-1605	102	1	commentary	commentary	NOUN
dpc-1605	102	2	|	|	ADV
dpc-1605	102	3	dermatol	dermatol	ADJ
dpc-1605	102	4	pract	pract	NOUN
dpc-1605	102	5	concept	concept	NOUN
dpc-1605	102	6	.	.	PUNCT
dpc-1605	103	1	2021	2021	NUM
dpc-1605	103	2	;	;	PUNCT
dpc-1605	103	3	11(4	11(4	NUM
dpc-1605	103	4	):	):	PUNCT
dpc-1605	103	5	e	e	NOUN
dpc-1605	103	6	2021120	2021120	NUM
dpc-1605	103	7	3	3	NUM
dpc-1605	103	8	10	10	NUM
dpc-1605	103	9	.	.	PUNCT
dpc-1605	104	1	vasques	vasque	NOUN
dpc-1605	104	2	f	f	X
dpc-1605	104	3	,	,	PUNCT
dpc-1605	104	4	behr	behr	PROPN
dpc-1605	104	5	au	au	PROPN
dpc-1605	104	6	,	,	PUNCT
dpc-1605	104	7	weinberg	weinberg	PROPN
dpc-1605	104	8	g	g	PROPN
dpc-1605	104	9	,	,	PUNCT
dpc-1605	104	10	ori	ori	PROPN
dpc-1605	104	11	c	c	X
dpc-1605	104	12	,	,	PUNCT
dpc-1605	104	13	di	di	PROPN
dpc-1605	104	14	gregorio	gregorio	PROPN
dpc-1605	104	15	g.	g.	PROPN
dpc-1605	104	16	a	a	DET
dpc-1605	104	17	review	review	NOUN
dpc-1605	104	18	of	of	ADP
dpc-1605	104	19	local	local	ADJ
dpc-1605	104	20	anesthetic	anesthetic	ADJ
dpc-1605	104	21	systemic	systemic	ADJ
dpc-1605	104	22	toxicity	toxicity	NOUN
dpc-1605	104	23	cases	case	NOUN
dpc-1605	104	24	since	since	SCONJ
dpc-1605	104	25	publication	publication	NOUN
dpc-1605	104	26	of	of	ADP
dpc-1605	104	27	the	the	DET
dpc-1605	104	28	american	american	ADJ
dpc-1605	104	29	society	society	NOUN
dpc-1605	104	30	of	of	ADP
dpc-1605	104	31	regional	regional	ADJ
dpc-1605	104	32	anesthesia	anesthesia	PROPN
dpc-1605	104	33	recommendations	recommendation	NOUN
dpc-1605	104	34	:	:	PUNCT
dpc-1605	104	35	to	to	PART
dpc-1605	104	36	whom	whom	PRON
dpc-1605	104	37	it	it	PRON
dpc-1605	104	38	may	may	AUX
dpc-1605	104	39	concern	concern	VERB
dpc-1605	104	40	.	.	PUNCT
dpc-1605	105	1	reg	reg	PROPN
dpc-1605	105	2	anesth	anesth	PROPN
dpc-1605	105	3	pain	pain	NOUN
dpc-1605	105	4	med	me	VERB
dpc-1605	105	5	.	.	PUNCT
dpc-1605	106	1	2015;40(6):698	2015;40(6):698	NUM
dpc-1605	106	2	-	-	PUNCT
dpc-1605	106	3	705	705	NUM
dpc-1605	106	4	.	.	PUNCT
dpc-1605	107	1	doi	doi	NOUN
dpc-1605	107	2	:	:	PUNCT
dpc-1605	107	3	10.1097	10.1097	NUM
dpc-1605	107	4	/	/	SYM
dpc-1605	107	5	aap.0000000000000320	aap.0000000000000320	PROPN
dpc-1605	107	6	.	.	PUNCT
dpc-1605	108	1	pmid	pmid	NOUN
dpc-1605	108	2	:	:	PUNCT
dpc-1605	108	3	26469367	26469367	NUM
dpc-1605	108	4	.	.	PUNCT
dpc-1605	109	1	11	11	NUM
dpc-1605	109	2	.	.	X
dpc-1605	109	3	starling	starle	VERB
dpc-1605	109	4	j	j	PROPN
dpc-1605	109	5	3rd	3rd	NOUN
dpc-1605	109	6	,	,	PUNCT
dpc-1605	109	7	thosani	thosani	PROPN
dpc-1605	109	8	mk	mk	PROPN
dpc-1605	109	9	,	,	PUNCT
dpc-1605	109	10	coldiron	coldiron	PROPN
dpc-1605	109	11	bm	bm	PROPN
dpc-1605	109	12	.	.	PUNCT
dpc-1605	110	1	determining	determine	VERB
dpc-1605	110	2	the	the	DET
dpc-1605	110	3	safety	safety	NOUN
dpc-1605	110	4	of	of	ADP
dpc-1605	110	5	office	office	NOUN
dpc-1605	110	6	-	-	PUNCT
dpc-1605	110	7	based	base	VERB
dpc-1605	110	8	surgery	surgery	NOUN
dpc-1605	110	9	:	:	PUNCT
dpc-1605	110	10	what	what	PRON
dpc-1605	110	11	10	10	NUM
dpc-1605	110	12	years	year	NOUN
dpc-1605	110	13	of	of	ADP
dpc-1605	110	14	florida	florida	PROPN
dpc-1605	110	15	data	datum	NOUN
dpc-1605	110	16	and	and	CCONJ
dpc-1605	110	17	6	6	NUM
dpc-1605	110	18	years	year	NOUN
dpc-1605	110	19	of	of	ADP
dpc-1605	110	20	alabama	alabama	PROPN
dpc-1605	110	21	data	datum	NOUN
dpc-1605	110	22	reveal	reveal	VERB
dpc-1605	110	23	.	.	PUNCT
dpc-1605	111	1	dermatol	dermatol	NOUN
dpc-1605	111	2	surg	surg	NOUN
dpc-1605	111	3	.	.	PUNCT
dpc-1605	112	1	2012;38(2):171	2012;38(2):171	NUM
dpc-1605	112	2	-	-	PUNCT
dpc-1605	112	3	177	177	NUM
dpc-1605	112	4	.	.	PUNCT
dpc-1605	113	1	doi	doi	NOUN
dpc-1605	113	2	:	:	PUNCT
dpc-1605	113	3	10.1111	10.1111	NUM
dpc-1605	113	4	/	/	SYM
dpc-1605	113	5	j.1524	j.1524	PROPN
dpc-1605	113	6	-	-	PUNCT
dpc-1605	113	7	4725.2011.02206.x	4725.2011.02206.x	NUM
dpc-1605	113	8	.	.	PUNCT
dpc-1605	114	1	pmid	pmid	NOUN
dpc-1605	114	2	:	:	PUNCT
dpc-1605	114	3	22093178	22093178	NUM
dpc-1605	114	4	.	.	PUNCT